Abstract
DISCLOSURES: No funding supported the writing of this commentary. Brummel has consulted, presented, or was engaged in an advisory board for UCB, Boerhinger Ingelheim, Pfizer, and Lilly. Sorenson has nothing to disclose.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1067-1070 |
| Number of pages | 4 |
| Journal | Journal of Managed Care and Specialty Pharmacy |
| Volume | 26 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2020 |
Fingerprint
Dive into the research topics of 'Twenty years of experience and counting: Strategies for growing medication therapy management services'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS